 Respironics is a leading global developer, manufacturer, and distributor of innovative products and programs for sleep and respiratory markets. The Critical Care Group helps clinicians avoid the complications of intubation with complete noninvasive ventilation (NIV) systems. When intubation is necessary, Respironics' ventilation solutions are part of the clinical treatment and liberation strategy. From ventilation setup to liberation, Respironics' world-class monitoring and decision support capabilities enable positive clinical and economic outcomes. Respironics NIV technology remains the standard for comfortable, effective treatment. The digital Auto-Trak™ sensitivity, which helped make the BiPAP® Vision® ventilator the standard for NIV, is now available in all ventilator platforms. With a complete line of patient interfaces, educational programs, and technical support offerings, Respironics NIV solutions provide a realistic alternative to intubation. Respironics liberation solutions address the needs of both clinicians and patients. The Esprit® critical care ventilator enables speech without a one-way valve, which simplifies the first step toward liberation for some patients. The NICO2® respiratory profile monitor helps clinicians assess patient readiness for self-breathing trials, and the Cadence™ system, indicated for the treatment of hypoxemia, can be used to support patients during these trials, which are typically the final bridge to liberation. |
|
|
|
||
|
||
